N.J. Admin. Code § 10:51-1.22 - Drug manufacturers' rebate agreement

(a) In order for legend drug products to be reimbursed by the New Jersey Medicaid or NJ FamilyCare program, manufacturers must have in effect a rebate agreement pursuant to Section 1927 et seq. of the Social Security Act (42 U.S.C. § 1396R-8(i)).

(b) Price information is supplied from a reference drug file subcontracted for this purpose by the fiscal agent and accepted by the Division as the primary source of pricing information for the New Jersey Medicaid Management Information System (NJMMIS). The calculated price shall not exceed the lower of the average wholesale price (AWP) or the Federal Fund Participation Upper Limit (FFPUL) as supplied by the reference drug file contractor.

Notes

N.J. Admin. Code § 10:51-1.22

Recodified from N.J.A.C. 10:51-1.21 by R.1998 d.154, effective 2/27/1998 (operative March 1, 1998; to expire August 31, 1998).
See: 30 New Jersey Register 1060(a).
Former N.J.A.C. 10:51-1.22, Bundled drug service, recodified to N.J.A.C. 10:51-1.23.
Adopted concurrent proposal, R.1998 d.487, effective 8/28/1998.
See: 30 New Jersey Register 1060(a), 30 New Jersey Register 3519(a).
Readopted the provisions of R.1998 d.154 without change.
Amended by R.1998 d.488, effective 9/21/1998.
See: 30 New Jersey Register 2169(b), 30 New Jersey Register 3538(a).
In (a), inserted a reference to NJ KidCare, and deleted OBRA reference.
Amended by R.2004 d.26, effective 1/20/2004.
See: 35 New Jersey Register 3788(a), 36 New Jersey Register 558(a).
In (a), substituted "NJ FamilyCare" for "NJ KidCare".